Deletion of the glutamate carboxypeptidase II gene in mice reveals a second enzyme activity that hydrolyzes N-acetylaspartylglutamate
- PMID: 12358725
- DOI: 10.1046/j.1471-4159.2002.01117.x
Deletion of the glutamate carboxypeptidase II gene in mice reveals a second enzyme activity that hydrolyzes N-acetylaspartylglutamate
Abstract
Glutamate carboxypeptidase II (GCPII, EC 3.14.17.21) is a membrane-bound enzyme found on the extracellular face ofglia. The gene for this enzyme is designated FOLH1 in humans and Folh1 in mice. This enzyme has been proposed to be responsible for inactivation of the neurotransmitter N-acetylaspartylglutamate (NAAG) following synaptic release. Mice harboring a disruption of the gene for GCPII/Folh1 were generated by inserting into the genome a targeting cassette in which the intron-exon boundary sequences of exons 1 and 2 were removed and stop codons were inserted in exons 1 and 2. Messenger RNA for GCPII was not detected by northern blotting or RT-PCR analysis of RNA from the brains of -/- mutant mice nor was GCPII protein detected on western blots of this tissue. These GCPII null mutant mice developed normally to adulthood and exhibited a normal range of neurologic responses and behaviors including mating, open field activity and retention of position in rotorod tests. No significant differences were observed among responses of wild type, heterozygous mutant and homozygous mutant mice on tail flick and hot plate latency tests. Glutamate, NAAG and mRNA for metabotropic glutamate receptor type 3 levels were not significantly altered in response to the deletion of glutamate carboxypeptidase II. A novel membrane-bound NAAG peptidase activity was discovered in brain, spinal cord and kidney of the GCPII knock out mice. The kinetic values for brain NAAG peptidase activity in the wild type and GCPII nullmutant were Vmax = 45 and 3 pmol/mg/min and Km = 2650 nm and 2494 nm, respectively. With the exception of magnesium and copper, this novel peptidase activity had a similar requirement for metal ions as GCPII. Two potent inhibitors of GCPII, 4,4'-phosphinicobis-(butane-1,3 dicarboxilic acid) (FN6) and 2-(phosphonomethyl)pentanedioic acid (2-PMPA) inhibited the residual activity. The IC50 value for 2-PMPA was about 1 nm for wild-type brain membrane NAAG peptidase activity consistent with its activity against cloned ratand human GCPII, and 88 nm for the activity in brain membranes of the null mutants.
Similar articles
-
The cloning and characterization of a second brain enzyme with NAAG peptidase activity.J Neurochem. 2004 May;89(3):627-35. doi: 10.1111/j.1471-4159.2004.02361.x. J Neurochem. 2004. PMID: 15086519
-
Regulation of glutamate carboxypeptidase II hydrolysis of N-acetylaspartylglutamate (NAAG) in crayfish nervous tissue is mediated by glial glutamate and acetylcholine receptors.J Neurochem. 2005 May;93(3):605-10. doi: 10.1111/j.1471-4159.2005.03041.x. J Neurochem. 2005. PMID: 15836619
-
Molecular modeling of the interactions of glutamate carboxypeptidase II with its potent NAAG-based inhibitors.J Med Chem. 2002 Sep 12;45(19):4140-52. doi: 10.1021/jm010561g. J Med Chem. 2002. PMID: 12213057
-
Still NAAG'ing After All These Years: The Continuing Pursuit of GCPII Inhibitors.Adv Pharmacol. 2016;76:215-55. doi: 10.1016/bs.apha.2016.01.007. Epub 2016 Mar 18. Adv Pharmacol. 2016. PMID: 27288079 Review.
-
N-acetylaspartylglutamate (NAAG) and glutamate carboxypeptidase II: An abundant peptide neurotransmitter-enzyme system with multiple clinical applications.Prog Neurobiol. 2020 Jan;184:101722. doi: 10.1016/j.pneurobio.2019.101722. Epub 2019 Nov 12. Prog Neurobiol. 2020. PMID: 31730793 Review.
Cited by
-
Peripheral ganglia in healthy rats as target structures for the evaluation of PSMA imaging agents.BMC Cancer. 2019 Jun 26;19(1):633. doi: 10.1186/s12885-019-5841-8. BMC Cancer. 2019. PMID: 31242896 Free PMC article.
-
More Than Meets the Eye: Scientific Rationale behind Molecular Imaging and Therapeutic Targeting of Prostate-Specific Membrane Antigen (PSMA) in Metastatic Prostate Cancer and Beyond.Cancers (Basel). 2021 May 7;13(9):2244. doi: 10.3390/cancers13092244. Cancers (Basel). 2021. PMID: 34067046 Free PMC article. Review.
-
GCP II (NAALADase) inhibition suppresses mossy fiber-CA3 synaptic neurotransmission by a presynaptic mechanism.J Neurophysiol. 2004 Jan;91(1):182-93. doi: 10.1152/jn.00465.2003. Epub 2003 Aug 13. J Neurophysiol. 2004. PMID: 12917384 Free PMC article.
-
Profound changes in cerebrospinal fluid proteome and metabolic profile are associated with congenital hydrocephalus.J Cereb Blood Flow Metab. 2021 Dec;41(12):3400-3414. doi: 10.1177/0271678X211039612. Epub 2021 Aug 20. J Cereb Blood Flow Metab. 2021. PMID: 34415213 Free PMC article.
-
PSMA redirects MAPK to PI3K-AKT signaling to promote prostate cancer progression.Mol Cell Oncol. 2017 Apr 28;4(4):e1321168. doi: 10.1080/23723556.2017.1321168. eCollection 2017. Mol Cell Oncol. 2017. PMID: 28868342 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous